Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SPACs
SPACs
Gene therapy biotech Medera looks back to SPAC as way to go public
Fierce Biotech
Thu, 09/5/24 - 11:27 am
Medera
SPACs
gene therapy
cardiovascular disease
SPACs back from brink with NK cell therapy biotech's plans for blank-check merger
Fierce Biotech
Fri, 03/24/23 - 10:12 am
SPACs
natural killer cell therapy
NKGen
cell therapy
Are biotech SPACs back? Cancer-focused Apollomics next to take blank-check route
Fierce Biotech
Thu, 09/15/22 - 11:27 pm
biotech
SPACs
Apollomics
Human Longevity makes a move toward Nasdaq with potential SPAC deal, but nothing's final yet
Endpoints
Tue, 06/21/22 - 11:57 am
Human Longevity
anti-aging
SPACs
SEC to propose new rules to rein in SPACs
Endpoints
Wed, 03/30/22 - 11:07 am
SEC
regulatory
SPACs
Drug discovery specialists at Ligand take their antibody biz public via SPAC, aiming to build $850M company
Endpoints
Thu, 03/24/22 - 10:51 am
Ligand Pharmaceuticals
drug discovery
OmniAb
SPACs
Three Biopharma Companies Heading to Nasdaq Through SPACs
BioSpace
Sun, 03/20/22 - 10:57 pm
SPACs
NASDAQ
Apexigen
Benuvia
Scilex
Crunch time for the SPAC space
EP Vantage
Sun, 02/27/22 - 10:18 pm
SPACs
Amicus Therapeutics
Valo Health
Khosla Ventures
Amicus exits gene therapy
EP Vantage
Fri, 02/25/22 - 09:32 am
Amicus Therapeutics
gene therapy
SPACs
spinoffs
Amicus' gene therapy SPAC merger folds, turning pipeline and R&D into target of $400M in cuts
Fierce Biotech
Thu, 02/24/22 - 09:28 am
Amicus Therapeutics
gene therapy
SPACs
R&D
With $825M SPAC merger, ProKidney sets stage for phase 3 trial of kidney disease cell therapy
Fierce Biotech
Tue, 01/18/22 - 11:58 pm
ProKidney
SPACs
cell therapy
clinical trials
kidney disease
5 questions facing biotech M&A in 2022
BioPharma Dive
Wed, 01/12/22 - 11:08 am
M&A
SPACs
pandemic
COVID-19
The latest healthcare SPAC comes in at $200M with a laser focus on artificial intelligence
Endpoints
Fri, 12/10/21 - 11:02 am
SPACs
funding
Healthcare AI Acquisition Corp
artificial intelligence
Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut
Fierce Pharma
Tue, 12/7/21 - 11:07 am
Alvotech
SPACs
AbbVie
Humira
AI-based drug discovery firm BenevolentAI cuts SPAC deal
Pharmaforum
Mon, 12/6/21 - 11:41 pm
drug discovery
artificial intelligence
BenevolentAI
SPACs
Europe
Digital health firm Pear goes public, raising $175 million
Pharmaforum
Mon, 12/6/21 - 10:32 am
Pear Therapeutics
digital health
SPACs
Robotics startup Vicarious files pre-submission with FDA, fresh from $425M SPAC raise
Medtech Dive
Tue, 11/9/21 - 10:30 am
devices
Medtech
robotic surgery
Vicarious Surgical
SPACs
FDA
Three more biotechs hit Nasdaq as the sector, now with more than $13B raised, continues barreling toward record
Endpoints
Wed, 09/15/21 - 10:56 am
IPOs
SPACs
NASDAQ
Pasithea Therapeutics
Tyra Biosciences
DiCE Therapeutics
Antiviral nasal drop maker does the Nasdaq shuffle as part of minor SPAC reverse merger
Endpoints
Tue, 08/31/21 - 11:02 am
Revelation Biosciences
antivirals
SPACs
NASDAQ
SPAC listings slow as the hunt for deals continues
EP Vantage
Mon, 07/12/21 - 10:38 am
SPACs
SEC
Pages
1
2
next ›
last »